British American Tobacco has agreed a $49.4bn (£40bn) deal to take control of US rival Reynolds, creating the world’s largest listed tobacco firm.
The UK company has been in talks with Reynolds for months about buying the 57.8% stake it does not already own.
The merger would see some of the tobacco industry’s best-known brands together, including Lucky Strike, Rothmans, Dunhill and Camel cigarettes.
A merger “creates a stronger, truly global tobacco” business, BAT said.
BAT, a shareholder in Reynolds since 2004, said last year that the merger was “the logical progression in our relationship”.
However, the UK company’s initial approaches were rebuffed by Reynolds, and a $47bn (£38.78bn) offer was rejected last November.
BAT estimates that it can make $400m (£329.92m) worth of cost-savings through the merger.
Reynolds is the second largest tobacco company in the US after Altria, which owns Philip Morris USA. The company has been operating since 1875.
Last year, Reynolds completed its $25bn (£20.62bn) takeover of US rival Lorillard. The combined company was forced to sell off a number of brands, including Kool, Salem and Winston, to satisfy regulators. They were eventually bought by Britain’s Imperial Tobacco for $7.1bn (£5.86bn).
Products by BAT include Rothmans, Kool and Kent, while Reynolds’ brands include Newport, Camel, Pall Mall, Doral, Misty and Capri.
The UK company has more than 200 brands, and is a big player in the market for e-cigarettes. The takeover will give it a further foothold in the US, and give the combined business a significant presence in high-growth markets including South America, the Middle East and Africa.
The offer comprises $25bn (£20.62bn) worth of BAT shares and $24.4bn (£20.13bn) in cash, valuing the whole Reynolds business at more than $85bn (£70.11bn). The sweetened deal represents a 26% premium against the closing price of Reynolds’ shares on 20 October, when news of BAT’s interest in taking full control of Reynolds emerged.
Nicandro Durante, BAT’s chief executive, said: “We have been shareholders in Reynolds since 2004 and we have benefited from the success of the present management team’s strategy, including its acquisition of Lorillard, which we supported with our own investment in 2015.
“Our combination with Reynolds will benefit from utilising the best talent from both organisations. It will create a stronger, global tobacco and NGP [new-generation products] business with direct access for our products across the most attractive markets in the world.”
The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.
Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.
Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.